Earlybird US Stock Notes for JAN 5, 2007

by Jon C.Ogg

Please note that this is a partial list that does not include international coverage, media coverage, and analyst calls.

(AAPL) Apple noted as Cramer’s #2 Growth Stock for 2007.
(AINV) Apollo Investment fell 1.5% after filing to sell 16 million shares.
(BAMM) Books-a-Million fell another 1.5% after falling 3% Thursday after beating revenues but posting lower s-s-s for December.
(BJRI) BJ’s Restaurants rose 1% after beating revenue expectations for the quarter.
(CPST) Capstone Turbine received $1.6 million in a follow-on order out of Russia.
(CSCO) Cisco Systems noted as Cramer’s #3 Growth Stock for 2007.
(DLTR) Dollar Tree traded up marginally after essentially reaffirming sales targets.
(DNA) Genentech reported Positive Phase II Pertusumab results after the close.
(HWAY) Healthways traded down 5% after reporting mixed earnings and revenue slightly under plan.
(MOT) Motorola lowered guidance on mobile device shortfalls; puts revenues at $11.6-11.8 billion instead of the prior $11.8-12.1 Billion; the real warning is on EPS at $0.23 to $0.26 instead of $0.38 and that is before a $0.10 special charges hickey.
(MRVL) Marvell Tech said it is raising some executive stock option exercise prices after option reviews.
(NYT) New York Times is selling its broadcasting division for $575 Million to focus on papers.
(NYX) NYSE noted as Cramer’s #1 Growth Stock for 2007.
(OPWV) Openwave traded down 5% after issuing anotherearnings warning for this quarter and next; company also announced it plans to waste up to $100M of shareholder money in share repurchases.
(RBAK) Reback lowered guidance, but this is under tender by Ericsson since December.
(RMBS) Rambus terminated former CEO’s outstanding stock options.
(RNOW) Rightnow Tech fell 12% after signalling a loss instead of break-even results.
(SABA) Saba Software traded up almost 5% after exceeding earnings estimates.
(SYNP) Synplicity shares traded down 27% after lowering guidance.
(TWTR) Tweeter fell more than 2% after announcing it missed sales expectations.
(XRTX) Xyratex fell about 3% after beating lowered guidance, fell because warned for next quarter.